Therapeutic uses and methods
US11976281B2 · kind B2 · utility
0Cited by
2References
13Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | May 6, 2019 |
| Grant date | May 7, 2024 |
| Priority date | — |
| Expiry date | Jun 20, 2039 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12N2320/35
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The specification discloses a method of treating muscular disorders such as muscular dystrophy comprising periodically administering an inhibitory oligonucleotide to human CD49d ((the alpha 4 chain of VLA-4).
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.